Previous Section
Review Articles
49. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
- Author
- Ogasawara, Toshie; Yasuyama, Masako; Kawauchi, Kiyotaka;
- Institution
- Tokyo Women's Medical University Daini Hospital, Department of Medicine, Tokyo 116-8567, Japan.
- Journal
- Am J Hematol 2005 Jun;79(2):136-41.
- Abstract URL
- Click here to view abstract
50. Bone marrow transplant in myelodysplastic syndromes: new technologies, same questions.
- Author
- Giralt, Sergio;
- Institution
- University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 462, Houston, TX 77030, USA.
- Journal
- Curr Hematol Rep 2005 May;4(3):200-7.
- Abstract URL
- Click here to view abstract
51. New agents in myelodysplastic syndromes.
- Author
- Jabbour, Elias J; Giles, Francis J;
- Institution
- Department of Leukemia, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77063, USA.
- Journal
- Curr Hematol Rep 2005 May;4(3):191-9.
- Abstract URL
- Click here to view abstract
52. The clinical implications of the World Health Organization's classification of myelodysplastic syndromes.
- Author
- Komrokji, Rami S; Bennett, John M;
- Institution
- James P Wilmot Cancer Center, Strong Memorial Hospital, University of Rochester, 601 Elmwood Avenue, Box 704, Rochester, NY 14642, USA.
- Journal
- Curr Hematol Rep 2005 May;4(3):175-81.
- Abstract URL
- Click here to view abstract
